NCT06166498 - Parasite Clearance and Protection From Infection (PCPI) in Zambia | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

December 19, 2024

Study Completion Date

March 5, 2025

Conditions

Malaria

Interventions

DRUG

SP (Macleods Pharmaceuticals Ltd)

Children who weigh \<10kg will receive Sulfadoxine-pyrimethamine paediatric formulation (250mg/12.5mg) dispersable tablets; children who weigh \>10kg will receive 500mg sulfadoxine plus 25mg pyrimethamine

DRUG

AS (Guilin Pharmaceuticals)

Children will receive 4 mg/kg/day for 7 days

Trial Locations (1)

Unknown

Nchelenge District, Nchelenge

All Listed Sponsors

lead

London School of Hygiene and Tropical Medicine

OTHER